Raymond James & Associates Decreases Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Raymond James & Associates trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 6.2% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 47,257 shares of the company’s stock after selling 3,112 shares during the quarter. Raymond James & Associates’ holdings in iShares U.S. Pharmaceuticals ETF were worth $3,337,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. McElhenny Sheffield Capital Management LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $18,942,000. Aptus Capital Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $12,165,000. Rockport Wealth LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $12,091,000. Concord Investment Counsel Inc. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 1st quarter valued at about $3,880,000. Finally, Southern Capital Advisors LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 2.4% during the 2nd quarter. Southern Capital Advisors LLC now owns 39,832 shares of the company’s stock valued at $2,642,000 after buying an additional 948 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 0.2 %

Shares of NYSEARCA IHE opened at $68.92 on Monday. The firm’s 50-day moving average price is $71.05 and its 200-day moving average price is $68.28. The stock has a market capitalization of $696.09 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a 12-month low of $56.03 and a 12-month high of $72.94.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.